Clinical Epidemiology and Ageing

Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units.

Toffart A-C, Dhalluin X, Girard N, Chouaid C, Audigier-Valette C, Duruisseaux M, Mennecier B, Parrot A, Fournel P, Moro-Sibilot D, Timsit J-F Intensive Care Med. 2015;41(1):164-5.
MeSH terms: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; France; Humans; Intensive Care Units; Lung Neoplasms; Male; Middle Aged; Mutation; Oncogene Proteins, Fusion; Patient Admission; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Survival Analysis; Treatment Outcome
DOI: 10.1007/s00134-014-3535-x